文献速递膀胱癌与上尿路尿路上皮癌肾癌与肾肿瘤前列腺癌

COVID-19疫情期间泌尿外科癌症手术延迟的文献综述

Delaying Cancer Cases in Urology during COVID-19: Review of the Literature.
PubMed 文献 · J Urol · 2020-07-25

本文综述膀胱癌、上尿路尿路上皮癌、阴茎癌、睾丸癌、前列腺癌、肾癌及肾上腺癌在COVID-19疫情期间手术延迟的文献,为泌尿外科医生优先安排肿瘤手术提供指导。结论强调识别具有潜在侵袭性肿瘤生物学的患者,使其获得早期治疗。

要点

  • 肌层浸润性膀胱癌延迟应小于约10周,并考虑新辅助化疗。
  • 高危上尿路尿路上皮癌(尤其输尿管肿瘤)应尽量减少延迟治疗。
  • 高危前列腺癌可优先治疗并考虑新辅助内分泌治疗。

核心结论

  • 本综述帮助泌尿外科医生识别具有潜在侵袭性肿瘤生物学的患者,这些患者需要早期治疗。

研究设计与样本

  • 本文为文献综述,回顾了膀胱癌、上尿路尿路上皮癌、阴茎癌、睾丸癌、前列腺癌、肾癌及肾上腺癌的相关已发表文献。

主要发现

  • 肌层浸润性膀胱癌延迟应小于约10周,并应考虑新辅助化疗。
  • 非肌层浸润性膀胱癌应根据风险进行适当咨询,膀胱内治疗可以继续。
  • 高危上尿路尿路上皮癌患者应尽量减少延迟治疗,尤其是输尿管肿瘤。
  • T1肾癌有手术指征时可延迟至资源充足时进行;T2肾癌若术前有不利特征应考虑早期手术;更高分期肾肿瘤应考虑早期手术;转移性肾癌推荐早期多学科诊疗。
  • 阴茎癌手术延迟过长可能导致更差的性功能或肿瘤学结局;肾上腺癌具有侵袭性需早期手术治疗;睾丸癌应按指征及时进行手术或化疗。

关键数值与推荐

  • 肌层浸润性膀胱癌手术延迟应小于约10周。
  • 高危前列腺癌可能需要优先治疗并考虑新辅助内分泌治疗。

临床怎么用

  • 在COVID-19疫情期间,泌尿外科医生应优先安排具有侵袭性肿瘤生物学的患者进行早期手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Coronavirus disease 2019 (COVID-19) is a global pandemic affecting hospital systems and the availability of resources for surgical procedures. Our aim is to provide guidance for urologists to help prioritize urological cancer surgeries. MATERIALS AND METHODS: We reviewed published literature on bladder cancer, upper tract urothelial carcinoma, penile cancer, testis cancer, prostate cancer, renal cancer and adrenal cancer. RESULTS: For muscle invasive bladder cancer delays should be less than roughly 10 weeks and neoadjuvant chemotherapy should be considered. Patients with nonmuscle invasive bladder cancer should be counseled appropriately based on risk and intravesical therapies can continue. Upper tract urothelial carcinoma should also be treated with minimal delays for high risk patients, especially with ureteral tumors. Surgery for T1 renal cancers when indicated can be delayed until adequate resources are available. Patients with T2 renal cancer should be considered for early surgery if there are unfavorable preoperative characteristics. Higher stage renal tumors should be considered for early surgery. An early multidisciplinary approach is recommended for metastatic renal cancers. High risk prostate cancer may need preferential treatment and consideration of neoadjuvant hormonal therapy. Penile cancer can have worse sexual or oncologic outcomes with prolonged surgical delay. Likewise, adrenal cancer is aggressive and needs early surgical treatment. Testicular cancer should be treated in a timely manner with surgery or chemotherapy, as indicated. CONCLUSIONS: This review should further assist urologists in recognizing patients with potentially aggressive tumor biology that warrants early treatment.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Tachibana I, Ferguson EL, Mahenthiran A, et al. Delaying Cancer Cases in Urology during COVID-19: Review of the Literature. J Urol. 2020. PMID: 32692934. doi:10.1097/JU.0000000000001288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。